|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 9/00 | (2013.01) |
| C07J 9/00 | (2006.01) | ||
| A61K 31/575 | (2006.01) | ||
| C07J 17/00 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 17/02 | (2018.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61P 25/20 | (2018.01) | ||
| A61P 25/22 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/16 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3529256 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17794488.1 |
| Date of filing the European patent application | 2017-10-18 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/057276 |
| Date | 2017-10-18 |
| (87) | Number | WO 2018/075698 |
| Date | 2018-04-26 |
| (30) | Number | Date | Country code |
| 201662409768 P | 2016-10-18 | US | |
| 201662409756 P | 2016-10-18 | US |
| (72) |
SALITURO, Francesco, G. , US
ROBICHAUD, Albert, J. , US
MARTINEZ BOTELLA, Gabriel , US
HARRISON, Boyd, L. , US
GRIFFIN, Andrew , CA
LA, Daniel , US
|
| (73) |
Sage Therapeutics, Inc. ,
215 First Street, Cambridge, MA 02142,
US
|
| (54) | OXYSTEROLS AND METHODS OF USE THEREOF |
| OXYSTEROLS AND METHODS OF USE THEREOF |